Novartis Leads Zurich Stocks Lower
April 24 2014 - 12:39PM
Dow Jones News
ZURICH--SMI falls 0.40% to 8409.13, with half of the shares in
the index showing losses for the day. Novartis (NOVN.VX) tumbles
1.9%, the biggest decliner in the index, after the pharmaceutical
firm posted profit and sales figures for the first quarter that
were below analysts' expectations. Actelion (ATLN.VX), the biggest
biotech firm in Europe, posted the second-largest decline of 1.72%.
Others ending the day with declines include UBS (UBSN.VX), down
0.11%, and fellow banking giant Credit Suisse (CSGN.VX), down
0.07%. Julius Baer (BAER.VX), up 0.47%, and Zurich Insurance
(ZURN.VX), up 0.24%, are among the gainers.
Write to Zurich bureau at djnews.zurich@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024